Please wait a minute...
Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology)  2011, Vol. 12 Issue (8): 652-659    DOI: 10.1631/jzus.B1101004
    
Effects of atorvastatin on progression of diabetic nephropathy and local RAGE and soluble RAGE expressions in rats
Lin Lu, Wen-hui Peng, Wei Wang, Ling-jie Wang, Qiu-jing Chen, Wei-feng Shen
Department of Cardiology, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200025, China, Institute of Cardiovascular Diseases, School of Medicine, Shanghai Jiao Tong University, Shanghai 200025, China
Download:     PDF (0 KB)     
Export: BibTeX | EndNote (RIS)      

Abstract  Objective: Advanced glycation end-products (AGEs) exert inflammatory and oxidative stress insults to produce diabetic nephropathy mainly through the receptor for AGEs (RAGE). This study aimed to assess the effect of atorvastatin on diabetic nephropathy via soluble RAGE (sRAGE) and RAGE expressions in the rat kidney. Methods: Thirty-two male Sprague-Dawley rats were divided into four groups based on the presence or absence of streptozotocin-induced diabetes with or without atorvastatin treatment (10 mg/kg for 24 weeks). Serum sRAGE and glycated albumin (GA) levels were measured with enzyme-linked immunosorbent assay (ELISA) and improved bromocresol purple methods. Renal AGEs, RAGE, endogenous secretory RAGE (esRAGE), and sRAGE were determined with reverse transcription-polymerase chain reaction (RT-PCR) and Western blotting. Results: Mesangial expansion and microalbuminuria were aggravated in diabetic rats, and improved with atorvastatin treatment. Serum sRAGE levels were lower in diabetic than in normal rats. After atorvastatin treatment, serum and renal sRAGE levels were up-regulated, while renal RAGE expression was decreased in diabetic rats, associated with a reduction in accumulation of AGEs, though renal esRAGE mRNA expression was not significantly increased. Conclusions: Atorvastatin exerted a beneficial effect on diabetic nephropathy with reduced AGE accumulation, down-regulating RAGE expression and up-regulating sRAGE in the kidney.

Key wordsReceptor for advanced glycation end-product (RAGE)      Endogenous secretory RAGE (esRAGE)      Soluble RAGE (sRAGE)      Diabetic nephropathy      Atorvastatin     
Received: 29 June 2011      Published: 02 August 2011
CLC:  R587.2  
  R961  
Cite this article:

Lin Lu, Wen-hui Peng, Wei Wang, Ling-jie Wang, Qiu-jing Chen, Wei-feng Shen. Effects of atorvastatin on progression of diabetic nephropathy and local RAGE and soluble RAGE expressions in rats. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2011, 12(8): 652-659.

URL:

http://www.zjujournals.com/xueshu/zjus-b/10.1631/jzus.B1101004     OR     http://www.zjujournals.com/xueshu/zjus-b/Y2011/V12/I8/652

[1] Hussam A. S. Murad. L-Carnitine, but not coenzyme Q10, enhances the anti-osteoporotic effect of atorvastatin in ovariectomized rats[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2016, 17(1): 43-53.
[2] You-qun Huang, Rong Gou, Yong-shu Diao, Qing-hua Yin, Wen-xing Fan, Ya-ping Liang, Yi Chen, Min Wu, Li Zang, Ling Li, Jing Zang, Lu Cheng, Ping Fu, Fang Liu. Charlson comorbidity index helps predict the risk of mortality for patients with type 2 diabetic nephropathy[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2014, 15(1): 58-66.
[3] Fang Liu, Min Wu, Yan-huan Feng, Hui Zhong, Tian-lei Cui, You-qun Huang, Ya-ping Liang, Yong-shu Diao, Li Zang, Ling Li, Jing Zang, Hong-yu Qiu, Song-min Huang, Ping Fu. Influence of HbA1c on short-term blood pressure variability in type 2 diabetic patients with diabetic nephropathy[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2013, 14(11): 1033-1040.
[4] Wen-xing Fan, Zheng-xu Deng, Fang Liu, Rong-bo Liu, Ling He, Bogati Amrit, Li Zang, Jing-wen Li, Xian-rong Liu, Song-min Huang, Ping Fu. Spontaneous retroperitoneal hemorrhage after hemodialysis involving anticoagulant agents[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2012, 13(5): 408-412.